These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26845947)

  • 1. [Impact of diet & exercise on HCV-infected patients].
    Kawaguchi T; Torimura T
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():290-3. PubMed ID: 26845947
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges for HCV vaccine development in HIV-HCV coinfection.
    Lambotin M; Barth H; Moog C; Habersetzer F; Baumert TF; Stoll-Keller F; Fafi-Kremer S
    Expert Rev Vaccines; 2012 Jul; 11(7):791-804. PubMed ID: 22913257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
    Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
    J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.
    Chemello L; Cavalletto L; Bernardinello E; Guido M; Pontisso P; Alberti A
    J Hepatol; 1995; 23 Suppl 2():8-12. PubMed ID: 8720287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The paradox of fatty diet on protease inhibitors against C hepatitis].
    Vida Pérez L
    Gastroenterol Hepatol; 2013 Oct; 36(8):549-50. PubMed ID: 23809310
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of six patients with chronic active HCV hepatitis, with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):253-7. PubMed ID: 8129569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The challenges of HIV-HCV co-infection].
    Ambrosioni J; Negro F; Calmy A
    Rev Med Suisse; 2012 Apr; 8(338):905-10. PubMed ID: 22611628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus diagnostics: technology, clinical applications and impacts.
    Conry-Cantilena C
    Trends Biotechnol; 1997 Feb; 15(2):71-6. PubMed ID: 9081301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predicting factors for the response to interferon therapy against hepatitis C virus infection: HCV genotyping].
    Yoshioka K; Kakumu S
    Rinsho Byori; 1994 Oct; 42(10):1010-4. PubMed ID: 7527870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-based therapy for chronic hepatitis C.
    Chang DY; Shin EC
    J Leukoc Biol; 2009 Jul; 86(1):33-9. PubMed ID: 19395471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol and coffee drinking and smoking habit among subjects with HCV infection.
    Zani C; Donato F; Chiesa M; Baiguera C; Gelatti U; Covolo L; Antonini MG; Nasta P; Gatti F; Orizio G; Puoti M
    Dig Liver Dis; 2009 Aug; 41(8):599-604. PubMed ID: 19185554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].
    Sarrazin C; Berg T; Ross RS; Schirmacher P; Wedemeyer H; Neumann U; Schmidt HH; Spengler U; Wirth S; Kessler HH; Peck-Radosavljevic M; Ferenci P; Vogel W; Moradpour D; Heim M; Cornberg M; Protzer U; Manns MP; Fleig WE; Dollinger MM; Zeuzem S
    Z Gastroenterol; 2010 Feb; 48(2):289-351. PubMed ID: 20119896
    [No Abstract]   [Full Text] [Related]  

  • 14. Why should infectious disease physicians care for the hepatitis C-infected patient?
    Godofsky E
    Infect Dis Clin North Am; 2012 Dec; 26(4):839-47. PubMed ID: 23083818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults.
    Chen EY; North CS; Fatunde O; Bernstein I; Salari S; Day B; Jain MK
    J Viral Hepat; 2013 Oct; 20(10):708-14. PubMed ID: 24010645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
    Bassett SE; Di Bisceglie AM; Bacon BR; Sharp RM; Govindarajan S; Hubbard GB; Brasky KM; Lanford RE
    Hepatology; 1999 Jun; 29(6):1884-92. PubMed ID: 10347134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C in haemophiliacs.
    Franchini M
    Thromb Haemost; 2004 Dec; 92(6):1259-68. PubMed ID: 15583731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy].
    Kaji K; Unoura M; Kobayashi K; Nakanuma Y
    Nihon Rinsho; 1994 Jul; 52(7):1865-8. PubMed ID: 7521432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.